Skip to Content

Join the 'Human Papillomavirus Prophylaxis' group to help and get support from people like you.

Human Papillomavirus Prophylaxis News

2 Doses of HPV Vaccine Effective for Younger Teens

Posted 10 days ago by Drugs.com

TUESDAY, Nov. 22, 2016 – New global research confirms that two doses of the vaccine for HPV, rather than three, can protect younger teens against the sexually transmitted virus. Based on this study and others, U.S. government health officials revised their guidelines last month to recommend a two-dose regimen for teens younger than 15. Prior to that revised guideline, three doses were recommended for adolescents and young adults up through 26 years of age. The vaccine protects against infection by HPV (human papillomavirus), which is the cause of 90 percent of cervical cancers, according to the U.S. National Cancer Institute. The new review included more than 1,500 young people, aged 9 to 26, who were vaccinated against HPV at 52 sites in 15 countries. For the study, the researchers gave two doses of HPV vaccine to teens aged 9 to 14, and three doses of the vaccine to older teens and ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

Routine School Vaccine Requirements Raise HPV Shot Rates, Too

Posted 8 Nov 2016 by Drugs.com

TUESDAY, Nov. 8, 2016 – Schools that require routine vaccines as a condition of attendance have higher rates of vaccination, including higher rates of immunization for the human papillomavirus (HPV), a new study finds. The HPV vaccine protects against cervical cancer, as well as other cancers linked to the sexually transmitted virus. Children at these schools are also more likely to get recommended shots for tetanus, diphtheria and pertussis (whooping cough) – the so-called Tdap shot – and meningitis (the meningococcal vaccine), researchers said. One pediatrician who reviewed the new findings believes school mandates can have a big influence on whether or not a child gets immunized. "Tdap and meningococcal vaccinations rates tend to be higher due to mandatory legislation as a requirement for school entry," said Dr. Jane Swedler, chief of adolescent medicine at Winthrop-University ... Read more

Related support groups: Tetanus, Gardasil, Pertussis, Cervarix, Human Papillomavirus Vaccine, Tetanus Immune Globulin, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Tetanus Prophylaxis, HyperTET S/D, Tri-Immunol, Diphtheria Toxoid/Haemophilus B Conjugate (Hboc) Vaccine/Pertussis, Whole Cell/Tetanus Toxoid, DTP Vaccine, Pertussis Prophylaxis, Hyper-Tet, Gardasil 9, Tetramune, BayTet, Diphtheria Toxoid/Pertussis, Whole Cell/Tetanus Toxoid, Diphtheria Prophylaxis

Anal Cancer Rates Rising in Many Parts of the World

Posted 2 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Anal cancer rates are on the rise in many countries. But vaccination against human papillomavirus (HPV) – a virus linked to the development of anal cancer – may help curb rates of the disease, a new study suggests. Researchers looked at data from the International Agency for Research on Cancer. The data included 18 countries. The investigators found that anal cancer rates have been increasing in women and men in 13 of those countries, particularly Australia and other countries in the Americas, and northern and western Europe. In those countries, a major subtype called anal squamous cell carcinoma (ASCC) was much more common than others, and was the main reason for the overall increasing rates of anal cancer. Rates of another major subtype, anal adenocarcinoma (AAC), have been stable or decreasing in most populations, the researchers said. "The reason for the ... Read more

Related support groups: Cancer, Colorectal Cancer, Human Papilloma Virus, Anal Fissure and Fistula, Condylomata Acuminata, Anal Itching, Gardasil, Human Papillomavirus Vaccine, Cervarix, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Gardasil 9

Are Fewer Cervical Cancer Screenings Needed After HPV Vaccine?

Posted 18 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Women who've been vaccinated against human papillomavirus (HPV) likely need fewer cervical cancer screenings, a new study argues. Just how often a woman needs a cervical cancer screening depends on the type of vaccine she had, the researchers said. Women vaccinated with earlier versions of the HPV vaccine – which protect against the two worst cancer-causing strains of the sexually transmitted virus – only need cervical cancer screening every five years starting at age 25 or 30, the study concluded. Women who've received the updated vaccine, which protects against seven cancer-causing strains of HPV, need screening even less often. The researchers recommend testing these women every 10 years starting at age 30 to 35 and ending at age 65. Both screening regimens would be much less rigorous than current guidelines, which call for cervical cancer exams from age 21 ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervical Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

How One Clinic Got a Big Boost in HPV Vaccination Rates

Posted 5 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 5, 2016 – The way to increase the number of girls and boys who get the human papillomavirus (HPV) vaccine may be as simple as giving it as part of a routine bundle of vaccines, a new study suggests. The HPV vaccine, which guards against the virus that causes most cervical cancers, is only being used in just over half of teen girls in the United States, lagging far behind other recommended vaccinations in this age group. But, by lumping HPV in with other required vaccinations, a Denver clinic was able to dramatically increase vaccination rates to nearly 90 percent in boys and girls, researchers report. "The program is simple and low cost, and something that can easily be rolled out at other institutions," said lead researcher Dr. Anna-Lisa Farmar. She is an assistant professor of pediatrics at the University of Colorado in Aurora. "It's become a part of our general ... Read more

Related support groups: Human Papilloma Virus, Gardasil, Cervarix, Human Papillomavirus Vaccine, Cervical Dysplasia, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

A Doctor's Words Key to Whether Child Gets HPV Vaccine

Posted 2 Oct 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – The language doctors use when recommending the human papillomavirus (HPV) vaccine can influence whether parents will have their children immunized, a new study finds. HPV causes most cases of cervical cancer and a large percentage of vaginal, vulvar, anal, penile and oropharyngeal cancers. The U.S. Centers for Disease Control and Prevention recommends boys and girls receive the three-dose HPV vaccination beginning at age 11 or 12. As of 2015, only 42 percent of girls and 28 percent of boys ages 13 to 17 had completed the HPV vaccine series, according to the CDC. Previous research found that doctors' recommendations play a major role in whether parents have their children vaccinated. In this new study, researchers examined if specific language used by doctors affects parents' decisions. The study included more than 1,500 parents. Their children were between the ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Head and Neck Cancer, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

HPV Vaccine More Effective Than Thought: Study

Posted 29 Sep 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – The vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, appears even more effective than believed, a new study finds. "After eight years of vaccination, the reduction in the incidence of cervical neoplasia [abnormal growth of cells], including pre-cancers, have been reduced approximately 50 percent. This is greater than what was expected – that's pretty exciting," said lead researcher Cosette Wheeler. She is a professor of pathology and obstetrics and gynecology at the University of New Mexico, in Albuquerque. The study also showed that the protection appears to occur even when only one or two of the recommended doses of the vaccine are given. "Right now, the recommendation is three doses for girls and boys before the 13th birthday, so that you are protected before you become exposed," Wheeler ... Read more

Related support groups: Gardasil, Human Papillomavirus Vaccine, Cervarix, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

More Parents Believe Vaccines Are Unnecessary

Posted 29 Aug 2016 by Drugs.com

MONDAY, Aug. 29, 2016 – Pediatricians are encountering more parents who refuse to have their children vaccinated, mainly because they don't see the point of vaccines, a U.S. survey found. In the survey, conducted in 2013, about 87 percent of pediatricians said they had encountered vaccine refusals, an increase from the 75 percent who reported refusals during the last survey from 2006. The most common reason, provided by three out of every four parents: Vaccines are unnecessary because the diseases they prevent have been wiped out in the United States. "Because these diseases are gone, people no longer fear them, even though many of them are only a plane ride away," said Dr. Kathryn Edwards, co-author of a new American Academy of Pediatrics report based on the survey. "They don't seem to realize that these diseases do exist in other places, and could come here." The percentage of ... Read more

Related support groups: Measles Virus Vaccine, Meningococcal Meningitis Prophylaxis, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, Influenza Prophylaxis, Human Papillomavirus Prophylaxis, Poliomyelitis Prophylaxis, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine, ProQuad, Tetanus Prophylaxis, Vaccination and Prophlaxis, M-M-R II, Diphtheria Prophylaxis, Measles Virus Vaccine/Rubella Virus Vaccine, Haemophilus influenzae Prophylaxis, Measles Prophylaxis, Attenuvax, Mumps Prophylaxis, M-R-Vax II, Pertussis Prophylaxis, Rubella Prophylaxis

Put Vaccines on Kids' Back-to-School List

Posted 21 Aug 2016 by Drugs.com

FRIDAY, Aug. 19, 2016 – As parents start preparing to send their young ones back to the classroom, the U.S. Food and Drug Administration says it's a good time to remember that vaccines play an important role in keeping children healthy. So, make sure your child is up-to-date on immunizations and fully protected from diseases such as measles, diphtheria, tetanus and pertussis (whooping cough), the agency advises. "Parents should know that vaccines protect children from many serious illnesses from infectious diseases. The risk of being harmed by vaccines is much smaller than the risk of serious illness from infectious diseases," Marion Gruber, director of the Office of Vaccines Research and Review at the FDA, said in an agency news release. Most side effects of vaccines are minor and temporary. For example, there may be soreness at the injection site or a child may develop a mild fever. ... Read more

Related support groups: Tetanus, Measles, Pertussis, Measles Virus Vaccine, Kinrix, Tetanus Immune Globulin, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, Pertussis, Acellular, Influenza Prophylaxis, ProQuad, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine, HyperTET S/D, Tripedia (DTaP), Daptacel (DTaP), Human Papillomavirus Prophylaxis, Poliomyelitis Prophylaxis, Diphtheria Toxoid/Pertussis, Acellular/Poliovirus Vaccine, Inactivated/Tetanus Toxoid, Boostrix (Tdap), Vaccination and Prophlaxis, Tetanus Prophylaxis

Cancer Experts Endorse CDC's HPV Vaccine Guidelines

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – The American Cancer Society has endorsed the U.S. government's HPV vaccination recommendations, which include immunizing all preteens against the sexually transmitted human papilloma virus. In a new report, the cancer society says 11- and 12-year-old girls as well as boys should be vaccinated to guard against cancers associated with HPV. This is in line with updated guidelines from the federal Centers for Disease Control and Prevention. "HPV vaccination has the potential to prevent tens of thousands of cancers and hundreds of thousands of pre-cancers each year," said the lead author of the report, Debbie Saslow. She is the cancer society's director of cancer control intervention for HPV vaccination and women's cancers. "It is critical that all stakeholders – families, health care providers, and others – make HPV vaccination a priority, so that prevention of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

HPV-Linked Cancers Still Climbing in U.S.

Posted 9 Jul 2016 by Drugs.com

THURSDAY, July 7, 2016 – Cancers linked to the sexually transmitted human papillomavirus (HPV) keep rising in the United States, even though most cases are preventable, health officials reported Thursday. Cervical cancer, and mouth and throat cancers in men, accounted for most of the nearly 39,000 HPV-associated cancers diagnosed annually from 2008 to 2012, according to the U.S. Centers for Disease Control and Prevention. HPV vaccination and cervical cancer screening could keep more than 28,000 of these cancers from developing, the agency estimated. "Most cervical cancers are preventable with regular screening for precancerous lesions among women aged 21 to 65 years, linked with follow-up for abnormal test results," the CDC researchers wrote in the report. But cancer experts said that public perception may have to change first, especially with respect to HPV vaccination. "In order to ... Read more

Related support groups: Condylomata Acuminata, Gardasil, Cervarix, Human Papillomavirus Vaccine, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9, Haemophilus influenzae Prophylaxis

1st HPV Test for Use With Preservative Fluid

Posted 8 Jul 2016 by Drugs.com

FRIDAY, July 8, 2016 – The U.S. Food and Drug Administration has approved Roche's cobas HPV Test – the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid. SurePath is an FDA-approved liquid collection fluid that's frequently used for Pap tests. But until this latest approval, no human papillomavirus (HPV) test had been approved to be used with the fluid, the FDA said in a news release. HPV strains account for some 70 percent of cervical cancers globally. The U.S. National Cancer Institute estimates there will be nearly 13,000 new cases of cervical cancer detected this year, and the disease will cause more than 4,100 deaths. The Swiss drugmaker Roche in 2012 warned that using cervical cells in SurePath fluid with an existing HPV test could produce false-negative results, the FDA said. This could have led to lack of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Diagnosis and Investigation, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

Study Hints at HPV Vaccine's Cancer Prevention Promise

Posted 5 Jul 2016 by Drugs.com

MONDAY, July 4, 2016 – The human papillomavirus (HPV) vaccine appears to prevent abnormalities that can lead to cervical cancer, a new study shows. Canadian researchers found that young women who received the vaccine through a school-based program were less likely to have such abnormalities when screened for cervical cancer than those who did not receive the vaccine. The young women were screened less than 10 years after they received their first HPV vaccine. The findings are from the province of Alberta. In 2008, Alberta introduced HPV vaccination for grade 5 girls (aged 10-11) and a three-year catch-up program for grade 9 girls (aged 14-15). The program provided three doses of the vaccine that protects against two strains of HPV. Those two strains of HPV account for 70 percent of all cases of cervical cancer, the researchers said. The study evaluated Pap test results for more than ... Read more

Related support groups: Human Papilloma Virus, Gardasil, Cervical Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

Vaccine Has Cut HPV Infection Rate in Teen Girls by Two-Thirds: Study

Posted 22 Feb 2016 by Drugs.com

MONDAY, Feb. 22, 2016 – Ten years of vaccinating against human papillomavirus (HPV) has cut infections from this cancer-causing virus by 64 percent among teen girls, U.S. health officials report. "We are continuing to see decreases in the HPV types that are targeted by the vaccine," said lead researcher Dr. Lauri Markowitz, a medical epidemiologist with the U.S. Centers for Disease Control and Prevention. These declines should lead to reductions in diseases caused by HPV, which include cervical cancer, and head and neck cancer, Markowitz said. However, it will take decades to see these reductions, because cancer takes years to develop, she added. "We have seen declines in genital warts [caused by HPV] already," she said. "The next thing we expect to see is a decline in pre-cancers, then later on declines in cancer." Although these findings are encouraging, too few young people are ... Read more

Related support groups: Cervical Cancer, Gardasil, Cervarix, Human Papillomavirus Vaccine, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

HPV Vaccine Rates Highest in Poor and Hispanic Communities: Study

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Teen girls in poor or predominately Hispanic communities are more likely to receive at least one dose of the human papillomavirus (HPV) vaccine than those in other communities, a new study finds. HPV can cause cancers of the cervix, vulva, vagina, anus, penis and throat, and the U.S. Centers for Disease Control and Prevention recommends that all girls and boys aged 11 to 12 receive three doses of the HPV vaccine. Researchers examined 2011 and 2012 CDC data on provider-verified vaccination records for more than 20,500 girls, aged 13 to 17. In each of those years, 53 percent of the girls received at least one dose of HPV vaccine. The highest vaccination initiation rate (69 percent) was among girls in predominately Hispanic communities and the lowest rates were among girls in predominately black communities (54 percent) and white communities (50 percent). Poverty ... Read more

Related support groups: Cancer, Human Papilloma Virus, Cervical Cancer, Gardasil, Head and Neck Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Human Papillomavirus Prophylaxis, Gardasil 9

Page 1 2 3 4 5 6 7 8 9 10 Next

Ask a Question

Further Information

Related Condition Support Groups

Vaccination and Prophlaxis

Related Drug Support Groups

Gardasil, human papillomavirus vaccine, Cervarix, Gardasil 9